NCT01508832View on ClinicalTrials.gov

Determination of the Duration of Action of a Lidocaine and a Bupivacaine Digital Nerve Block in Human Volunteers

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2013

Conditions
Onset and Duration of a Digital Nerve Block
Interventions
DRUG

Lidocaine Digital Nerve Block

Lidocaine 1% Digital Nerve Block (2 cc

DRUG

Bupivacaine Digital Block

Bupivacaine 0.25% Digital Block (2 cc)

Trial Locations (1)

94143

University of California San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT01508832 - Determination of the Duration of Action of a Lidocaine and a Bupivacaine Digital Nerve Block in Human Volunteers | Biotech Hunter | Biotech Hunter